Larvol Delta - Study-of-the-ITK-Inhibitor-Soquelitinib-to-Reduce-Lymphoproliferation-and-Improve-Cytopenias-in-Autoimmune-Lymphoproliferative-Syndrome-ALPSFAS-Patients

soquelitinib (CPI-818) - Corvus Pharma

http://clinicaltrials.gov/ct2/show/NCT06730126

Mar 21, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next